 | • レポートコード：QFJ1-5810 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、鉄欠乏性貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（処方薬、市販薬（OTC））、用途別市場規模（子供用、大人用、高齢者用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・鉄欠乏性貧血治療薬の市場動向 ・企業の競争状況、市場シェア ・鉄欠乏性貧血治療薬の種類別市場規模と予測2016-2027（処方薬、市販薬（OTC）） ・鉄欠乏性貧血治療薬の用途別市場規模と予測2016-2027（子供用、大人用、高齢者用） ・鉄欠乏性貧血治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・鉄欠乏性貧血治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・鉄欠乏性貧血治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鉄欠乏性貧血治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・鉄欠乏性貧血治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AMAG Pharmaceuticals, Inc、Meda Consumer Healthcare Inc、American Regent, Inc、GSK、Avion Pharmaceuticals, LLC、Bausch Health Companies Inc、Colorado BiolabsInc、Prestige Consumer Healthcare Inc、Keryx Biopharmaceuticals, Inc、Daiichi Sankyo, Inc.、DSE Healthcare Solutions, LLC） ・結論 |
Iron deficiency anemia is a decrease in the red cells of the blood caused by too little iron.The most economical and effective medical treatment for iron deficiency anemia is the oral administration of ferrous iron salts.
Market Analysis and Insights: Global Iron Deficiency Anemia Drug Market
The global Iron Deficiency Anemia Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Iron Deficiency Anemia Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Iron Deficiency Anemia Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Iron Deficiency Anemia Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Iron Deficiency Anemia Drug market.
Global Iron Deficiency Anemia Drug Scope and Market Size
Iron Deficiency Anemia Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Iron Deficiency Anemia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Prescription Drugs
Over-the-Counter (OTC)
Segment by Application
Child
Adult
Elderly
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AMAG Pharmaceuticals, Inc
Meda Consumer Healthcare Inc
American Regent, Inc
GSK
Avion Pharmaceuticals, LLC
Bausch Health Companies Inc
Colorado BiolabsInc
Prestige Consumer Healthcare Inc
Keryx Biopharmaceuticals, Inc
Daiichi Sankyo, Inc.
DSE Healthcare Solutions, LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iron Deficiency Anemia Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 Over-the-Counter (OTC)
1.3 Market by Application
1.3.1 Global Iron Deficiency Anemia Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Iron Deficiency Anemia Drug Market Perspective (2016-2027)
2.2 Iron Deficiency Anemia Drug Growth Trends by Regions
2.2.1 Iron Deficiency Anemia Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Iron Deficiency Anemia Drug Historic Market Share by Regions (2016-2021)
2.2.3 Iron Deficiency Anemia Drug Forecasted Market Size by Regions (2022-2027)
2.3 Iron Deficiency Anemia Drug Industry Dynamic
2.3.1 Iron Deficiency Anemia Drug Market Trends
2.3.2 Iron Deficiency Anemia Drug Market Drivers
2.3.3 Iron Deficiency Anemia Drug Market Challenges
2.3.4 Iron Deficiency Anemia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iron Deficiency Anemia Drug Players by Revenue
3.1.1 Global Top Iron Deficiency Anemia Drug Players by Revenue (2016-2021)
3.1.2 Global Iron Deficiency Anemia Drug Revenue Market Share by Players (2016-2021)
3.2 Global Iron Deficiency Anemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Iron Deficiency Anemia Drug Revenue
3.4 Global Iron Deficiency Anemia Drug Market Concentration Ratio
3.4.1 Global Iron Deficiency Anemia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iron Deficiency Anemia Drug Revenue in 2020
3.5 Iron Deficiency Anemia Drug Key Players Head office and Area Served
3.6 Key Players Iron Deficiency Anemia Drug Product Solution and Service
3.7 Date of Enter into Iron Deficiency Anemia Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iron Deficiency Anemia Drug Breakdown Data by Type
4.1 Global Iron Deficiency Anemia Drug Historic Market Size by Type (2016-2021)
4.2 Global Iron Deficiency Anemia Drug Forecasted Market Size by Type (2022-2027)
5 Iron Deficiency Anemia Drug Breakdown Data by Application
5.1 Global Iron Deficiency Anemia Drug Historic Market Size by Application (2016-2021)
5.2 Global Iron Deficiency Anemia Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Iron Deficiency Anemia Drug Market Size (2016-2027)
6.2 North America Iron Deficiency Anemia Drug Market Size by Type
6.2.1 North America Iron Deficiency Anemia Drug Market Size by Type (2016-2021)
6.2.2 North America Iron Deficiency Anemia Drug Market Size by Type (2022-2027)
6.2.3 North America Iron Deficiency Anemia Drug Market Size by Type (2016-2027)
6.3 North America Iron Deficiency Anemia Drug Market Size by Application
6.3.1 North America Iron Deficiency Anemia Drug Market Size by Application (2016-2021)
6.3.2 North America Iron Deficiency Anemia Drug Market Size by Application (2022-2027)
6.3.3 North America Iron Deficiency Anemia Drug Market Size by Application (2016-2027)
6.4 North America Iron Deficiency Anemia Drug Market Size by Country
6.4.1 North America Iron Deficiency Anemia Drug Market Size by Country (2016-2021)
6.4.2 North America Iron Deficiency Anemia Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Iron Deficiency Anemia Drug Market Size (2016-2027)
7.2 Europe Iron Deficiency Anemia Drug Market Size by Type
7.2.1 Europe Iron Deficiency Anemia Drug Market Size by Type (2016-2021)
7.2.2 Europe Iron Deficiency Anemia Drug Market Size by Type (2022-2027)
7.2.3 Europe Iron Deficiency Anemia Drug Market Size by Type (2016-2027)
7.3 Europe Iron Deficiency Anemia Drug Market Size by Application
7.3.1 Europe Iron Deficiency Anemia Drug Market Size by Application (2016-2021)
7.3.2 Europe Iron Deficiency Anemia Drug Market Size by Application (2022-2027)
7.3.3 Europe Iron Deficiency Anemia Drug Market Size by Application (2016-2027)
7.4 Europe Iron Deficiency Anemia Drug Market Size by Country
7.4.1 Europe Iron Deficiency Anemia Drug Market Size by Country (2016-2021)
7.4.2 Europe Iron Deficiency Anemia Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Iron Deficiency Anemia Drug Market Size (2016-2027)
8.2 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type
8.2.1 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application
8.3.1 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region
8.4.1 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Iron Deficiency Anemia Drug Market Size (2016-2027)
9.2 Latin America Iron Deficiency Anemia Drug Market Size by Type
9.2.1 Latin America Iron Deficiency Anemia Drug Market Size by Type (2016-2021)
9.2.2 Latin America Iron Deficiency Anemia Drug Market Size by Type (2022-2027)
9.2.3 Latin America Iron Deficiency Anemia Drug Market Size by Type (2016-2027)
9.3 Latin America Iron Deficiency Anemia Drug Market Size by Application
9.3.1 Latin America Iron Deficiency Anemia Drug Market Size by Application (2016-2021)
9.3.2 Latin America Iron Deficiency Anemia Drug Market Size by Application (2022-2027)
9.3.3 Latin America Iron Deficiency Anemia Drug Market Size by Application (2016-2027)
9.4 Latin America Iron Deficiency Anemia Drug Market Size by Country
9.4.1 Latin America Iron Deficiency Anemia Drug Market Size by Country (2016-2021)
9.4.2 Latin America Iron Deficiency Anemia Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iron Deficiency Anemia Drug Market Size (2016-2027)
10.2 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type
10.2.1 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application
10.3.1 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country
10.4.1 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals, Inc
11.1.1 AMAG Pharmaceuticals, Inc Company Details
11.1.2 AMAG Pharmaceuticals, Inc Business Overview
11.1.3 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Introduction
11.1.4 AMAG Pharmaceuticals, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.1.5 AMAG Pharmaceuticals, Inc Recent Development
11.2 Meda Consumer Healthcare Inc
11.2.1 Meda Consumer Healthcare Inc Company Details
11.2.2 Meda Consumer Healthcare Inc Business Overview
11.2.3 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Introduction
11.2.4 Meda Consumer Healthcare Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.2.5 Meda Consumer Healthcare Inc Recent Development
11.3 American Regent, Inc
11.3.1 American Regent, Inc Company Details
11.3.2 American Regent, Inc Business Overview
11.3.3 American Regent, Inc Iron Deficiency Anemia Drug Introduction
11.3.4 American Regent, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.3.5 American Regent, Inc Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Iron Deficiency Anemia Drug Introduction
11.4.4 GSK Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Avion Pharmaceuticals, LLC
11.5.1 Avion Pharmaceuticals, LLC Company Details
11.5.2 Avion Pharmaceuticals, LLC Business Overview
11.5.3 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Introduction
11.5.4 Avion Pharmaceuticals, LLC Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.5.5 Avion Pharmaceuticals, LLC Recent Development
11.6 Bausch Health Companies Inc
11.6.1 Bausch Health Companies Inc Company Details
11.6.2 Bausch Health Companies Inc Business Overview
11.6.3 Bausch Health Companies Inc Iron Deficiency Anemia Drug Introduction
11.6.4 Bausch Health Companies Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.6.5 Bausch Health Companies Inc Recent Development
11.7 Colorado BiolabsInc
11.7.1 Colorado BiolabsInc Company Details
11.7.2 Colorado BiolabsInc Business Overview
11.7.3 Colorado BiolabsInc Iron Deficiency Anemia Drug Introduction
11.7.4 Colorado BiolabsInc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.7.5 Colorado BiolabsInc Recent Development
11.8 Prestige Consumer Healthcare Inc
11.8.1 Prestige Consumer Healthcare Inc Company Details
11.8.2 Prestige Consumer Healthcare Inc Business Overview
11.8.3 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Introduction
11.8.4 Prestige Consumer Healthcare Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.8.5 Prestige Consumer Healthcare Inc Recent Development
11.9 Keryx Biopharmaceuticals, Inc
11.9.1 Keryx Biopharmaceuticals, Inc Company Details
11.9.2 Keryx Biopharmaceuticals, Inc Business Overview
11.9.3 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Introduction
11.9.4 Keryx Biopharmaceuticals, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.9.5 Keryx Biopharmaceuticals, Inc Recent Development
11.10 Daiichi Sankyo, Inc.
11.10.1 Daiichi Sankyo, Inc. Company Details
11.10.2 Daiichi Sankyo, Inc. Business Overview
11.10.3 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Introduction
11.10.4 Daiichi Sankyo, Inc. Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.10.5 Daiichi Sankyo, Inc. Recent Development
11.11 DSE Healthcare Solutions, LLC
11.11.1 DSE Healthcare Solutions, LLC Company Details
11.11.2 DSE Healthcare Solutions, LLC Business Overview
11.11.3 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Introduction
11.11.4 DSE Healthcare Solutions, LLC Revenue in Iron Deficiency Anemia Drug Business (2016-2021)
11.11.5 DSE Healthcare Solutions, LLC Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Iron Deficiency Anemia Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of Over-the-Counter (OTC)
Table 4. Global Iron Deficiency Anemia Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Iron Deficiency Anemia Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Iron Deficiency Anemia Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Iron Deficiency Anemia Drug Market Share by Regions (2016-2021)
Table 8. Global Iron Deficiency Anemia Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Iron Deficiency Anemia Drug Market Share by Regions (2022-2027)
Table 10. Iron Deficiency Anemia Drug Market Trends
Table 11. Iron Deficiency Anemia Drug Market Drivers
Table 12. Iron Deficiency Anemia Drug Market Challenges
Table 13. Iron Deficiency Anemia Drug Market Restraints
Table 14. Global Iron Deficiency Anemia Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Iron Deficiency Anemia Drug Market Share by Players (2016-2021)
Table 16. Global Top Iron Deficiency Anemia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Deficiency Anemia Drug as of 2020)
Table 17. Ranking of Global Top Iron Deficiency Anemia Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Iron Deficiency Anemia Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Iron Deficiency Anemia Drug Product Solution and Service
Table 21. Date of Enter into Iron Deficiency Anemia Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Iron Deficiency Anemia Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Iron Deficiency Anemia Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Iron Deficiency Anemia Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Iron Deficiency Anemia Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Iron Deficiency Anemia Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Iron Deficiency Anemia Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Iron Deficiency Anemia Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Iron Deficiency Anemia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Iron Deficiency Anemia Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Iron Deficiency Anemia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Iron Deficiency Anemia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Iron Deficiency Anemia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Iron Deficiency Anemia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Iron Deficiency Anemia Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Iron Deficiency Anemia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Iron Deficiency Anemia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Iron Deficiency Anemia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Iron Deficiency Anemia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Iron Deficiency Anemia Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Iron Deficiency Anemia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Iron Deficiency Anemia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Iron Deficiency Anemia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. AMAG Pharmaceuticals, Inc Company Details
Table 62. AMAG Pharmaceuticals, Inc Business Overview
Table 63. AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Product
Table 64. AMAG Pharmaceuticals, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 65. AMAG Pharmaceuticals, Inc Recent Development
Table 66. Meda Consumer Healthcare Inc Company Details
Table 67. Meda Consumer Healthcare Inc Business Overview
Table 68. Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Product
Table 69. Meda Consumer Healthcare Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 70. Meda Consumer Healthcare Inc Recent Development
Table 71. American Regent, Inc Company Details
Table 72. American Regent, Inc Business Overview
Table 73. American Regent, Inc Iron Deficiency Anemia Drug Product
Table 74. American Regent, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 75. American Regent, Inc Recent Development
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Iron Deficiency Anemia Drug Product
Table 79. GSK Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 80. GSK Recent Development
Table 81. Avion Pharmaceuticals, LLC Company Details
Table 82. Avion Pharmaceuticals, LLC Business Overview
Table 83. Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Product
Table 84. Avion Pharmaceuticals, LLC Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 85. Avion Pharmaceuticals, LLC Recent Development
Table 86. Bausch Health Companies Inc Company Details
Table 87. Bausch Health Companies Inc Business Overview
Table 88. Bausch Health Companies Inc Iron Deficiency Anemia Drug Product
Table 89. Bausch Health Companies Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 90. Bausch Health Companies Inc Recent Development
Table 91. Colorado BiolabsInc Company Details
Table 92. Colorado BiolabsInc Business Overview
Table 93. Colorado BiolabsInc Iron Deficiency Anemia Drug Product
Table 94. Colorado BiolabsInc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 95. Colorado BiolabsInc Recent Development
Table 96. Prestige Consumer Healthcare Inc Company Details
Table 97. Prestige Consumer Healthcare Inc Business Overview
Table 98. Prestige Consumer Healthcare Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 99. Prestige Consumer Healthcare Inc Recent Development
Table 100. Keryx Biopharmaceuticals, Inc Company Details
Table 101. Keryx Biopharmaceuticals, Inc Business Overview
Table 102. Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Product
Table 103. Keryx Biopharmaceuticals, Inc Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 104. Keryx Biopharmaceuticals, Inc Recent Development
Table 105. Daiichi Sankyo, Inc. Company Details
Table 106. Daiichi Sankyo, Inc. Business Overview
Table 107. Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Product
Table 108. Daiichi Sankyo, Inc. Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 109. Daiichi Sankyo, Inc. Recent Development
Table 110. DSE Healthcare Solutions, LLC Company Details
Table 111. DSE Healthcare Solutions, LLC Business Overview
Table 112. DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Product
Table 113. DSE Healthcare Solutions, LLC Revenue in Iron Deficiency Anemia Drug Business (2016-2021) & (US$ Million)
Table 114. DSE Healthcare Solutions, LLC Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iron Deficiency Anemia Drug Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. Over-the-Counter (OTC) Features
Figure 4. Global Iron Deficiency Anemia Drug Market Share by Application: 2020 VS 2027
Figure 5. Child Case Studies
Figure 6. Adult Case Studies
Figure 7. Elderly Case Studies
Figure 8. Iron Deficiency Anemia Drug Report Years Considered
Figure 9. Global Iron Deficiency Anemia Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Iron Deficiency Anemia Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Iron Deficiency Anemia Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Iron Deficiency Anemia Drug Market Share by Regions (2022-2027)
Figure 13. Global Iron Deficiency Anemia Drug Market Share by Players in 2020
Figure 14. Global Top Iron Deficiency Anemia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Deficiency Anemia Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Iron Deficiency Anemia Drug Revenue in 2020
Figure 16. Global Iron Deficiency Anemia Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Iron Deficiency Anemia Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Iron Deficiency Anemia Drug Market Share by Type (2016-2027)
Figure 20. North America Iron Deficiency Anemia Drug Market Share by Application (2016-2027)
Figure 21. North America Iron Deficiency Anemia Drug Market Share by Country (2016-2027)
Figure 22. United States Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Iron Deficiency Anemia Drug Market Share by Type (2016-2027)
Figure 26. Europe Iron Deficiency Anemia Drug Market Share by Application (2016-2027)
Figure 27. Europe Iron Deficiency Anemia Drug Market Share by Country (2016-2027)
Figure 28. Germany Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Iron Deficiency Anemia Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Iron Deficiency Anemia Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Iron Deficiency Anemia Drug Market Share by Region (2016-2027)
Figure 38. China Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Iron Deficiency Anemia Drug Market Share by Type (2016-2027)
Figure 46. Latin America Iron Deficiency Anemia Drug Market Share by Application (2016-2027)
Figure 47. Latin America Iron Deficiency Anemia Drug Market Share by Country (2016-2027)
Figure 48. Mexico Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Iron Deficiency Anemia Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Iron Deficiency Anemia Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Iron Deficiency Anemia Drug Market Share by Country (2016-2027)
Figure 54. Turkey Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Iron Deficiency Anemia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AMAG Pharmaceuticals, Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 58. Meda Consumer Healthcare Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 59. American Regent, Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 60. GSK Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 61. Avion Pharmaceuticals, LLC Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 62. Bausch Health Companies Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 63. Colorado BiolabsInc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 64. Prestige Consumer Healthcare Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 65. Keryx Biopharmaceuticals, Inc Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 66. Daiichi Sankyo, Inc. Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 67. DSE Healthcare Solutions, LLC Revenue Growth Rate in Iron Deficiency Anemia Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の貧血治療薬市場規模・現状・予測（2021年-2027年） Anemia is a condition in which you don't have enough healthy red blood cells to carry adequate oxygen to the body's tissues. Market Analysis and Insights: Global Anemia Treatment Drugs Market The global Anemia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX mill…- ファンコニ貧血薬のグローバル市場調査 2019年 The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年） CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were fi…
- 世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年） ACTH is an adrenocorticotropic hormone, which is a hormone secreted by the anterior pituitary gland, which can maintain the normal form and function of the adrenal glands. The main role of ACTH is to promote the secretion of glucocorticoids by the adrenal cortex, maintaining the normal physiological…
- 世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Treatment Market The global Arginase Deficiency Treatme…